QoL questionnaires

OTHER4 trials

Sponsors

Gruppo Italiano Malattie EMatologiche dell'Adulto, Holostem s.r.l., Memorial Sloan Kettering Cancer Center, Centre Hospitalier Universitaire de Besancon

Conditions

Acute Promyelocytic LeukemiaColorectal CancerColorectal CarcinomaColorectal NeoplasmsLimbal Stem Cell Deficiency Due to Ocular BurnOncology

Unknown Phase

Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy

Gruppo Italiano Malattie EMatologiche dell'AdultoAcute Promyelocytic Leukemia

Start: 2017-03-27End: 2022-01-31Target: 161Updated: 2021-02-08

Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns

CompletedNCT03288844

Holostem s.r.l.Limbal Stem Cell Deficiency Due to Ocular Burn

Start: 2017-12-13End: 2023-03-31Updated: 2023-05-26

Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer

RecruitingNCT04812912

Memorial Sloan Kettering Cancer CenterColorectal Cancer, Colorectal Carcinoma, Colorectal Neoplasms

Start: 2021-03-18End: 2027-03-18Target: 120Updated: 2026-04-07

Quality of Life Assessment for Early Identification of Supportive Care Needs in Oncology Patients

Not yet recruitingNCT06337487

Centre Hospitalier Universitaire de BesanconOncology

Start: 2024-03-31End: 2025-08-31Target: 93Updated: 2024-03-29

Related Papers

Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trial.

2024-10-23

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy

Blood Advances2021-09-1614 citations